-
公开(公告)号：US20090136482A1
公开(公告)日：2009-05-28
申请号：US12065303
申请日：2006-09-01
申请人： Yorimasa Suwa , Tadakazu Yamauchi , Morikazu Kito , Yuko Isono , Tsuruki Tamura , Motoi Tobita
发明人： Yorimasa Suwa , Tadakazu Yamauchi , Morikazu Kito , Yuko Isono , Tsuruki Tamura , Motoi Tobita
IPC分类号： A61K39/395 , G01N33/00 , C12Q1/68 , G01N33/566 , A61K38/02 , A61K31/7088 , A61K31/7105
CPC分类号： G01N33/68 , A61K45/06 , C07K14/47 , G01N33/5008 , G01N33/502 , G01N33/6845 , G01N33/94 , G01N2500/00 , Y10T436/143333
摘要： The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. More specifically, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
摘要翻译： 本发明提供了用于生物活性物质如药物的靶蛋白和靶基因，并且使得能够开发使用其的新型生物活性物质的手段。 更具体地，本发明提供用于生物活性物质的靶蛋白和靶基因; 能够调节生物活性的物质的筛选方法; 生物活性调节剂 生物活性物质衍生物生产方法; 包含生物活性物质和靶蛋白质的复合物，以及生产该复合物的方法; 和包含生物活性物质或其盐的试剂盒; 特定疾病或病症的发病或发病风险的确定方法，对生物活性物质易感性的测定方法和用于测定方法的测定试剂盒等。
-
2.发明申请公开(公告)号：US20100136524A1
公开(公告)日：2010-06-03
申请号：US11577350
申请日：2005-10-18
申请人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Motoi Tobita , Yorimasa Suwa
发明人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Motoi Tobita , Yorimasa Suwa
IPC分类号： C12Q1/68 , C07D403/12 , C07D401/12 , C07K14/00 , C12N15/63
CPC分类号： C07D211/22 , C07D235/30 , C07D235/32 , C07D295/08 , C07D409/06 , C07D417/04 , G01N33/6893 , G01N2500/00
摘要： The present invention provides a novel target protein and a gene for drug discovery, and a means that enables development of a novel pharmaceutical agent by using the same. More particularly, the present invention provides CARP and genes thereof; screening methods for drugs (e.g., antiallergic drugs); a regulator of diseases (e.g., allergic diseases); a drug derivative production method; a complex comprising a drug and CARP, and a production method thereof; kits comprising a drug or a salt thereof; determination methods for the onset or risk of onset of a specified disease, determination methods for susceptibility to a drug, and determination kits used for said methods, and the like.
摘要翻译： 本发明提供了一种新的靶蛋白和用于药物发现的基因，并且是通过使用它们能够开发新型药剂的方法。 更具体地，本发明提供CARP及其基因; 药物筛选方法（如抗过敏药物）; 疾病调节剂（如过敏性疾病）; 药物衍生物生产方法; 包含药物和CARP的复合物及其制备方法; 包含药物或其盐的试剂盒; 确定特定疾病发病或发病风险的方法，对药物易感性的测定方法和用于所述方法的测定试剂盒等。
-
公开(公告)号：US08153385B2
公开(公告)日：2012-04-10
申请号：US11577350
申请日：2005-10-18
申请人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Motoi Tobita , Yorimasa Suwa
发明人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Motoi Tobita , Yorimasa Suwa
IPC分类号： G01N33/53
CPC分类号： C07D211/22 , C07D235/30 , C07D235/32 , C07D295/08 , C07D409/06 , C07D417/04 , G01N33/6893 , G01N2500/00
摘要： The present invention provides a novel target protein and a gene for drug discovery, and a means that enables development of a novel pharmaceutical agent by using the same. More particularly, the present invention provides CARP and genes thereof; screening methods for drugs (e.g., antiallergic drugs); a regulator of diseases (e.g., allergic diseases); a drug derivative production method; a complex comprising a drug and CARP, and a production method thereof; kits comprising a drug or a salt thereof; determination methods for the onset or risk of onset of a specified disease, determination methods for susceptibility to a drug, and determination kits used for said methods, and the like.
摘要翻译： 本发明提供了一种新的靶蛋白和用于药物发现的基因，并且是通过使用它们能够开发新型药剂的方法。 更具体地，本发明提供CARP及其基因; 药物筛选方法（如抗过敏药物）; 疾病调节剂（如过敏性疾病）; 药物衍生物生产方法; 包含药物和CARP的复合物及其制备方法; 包含药物或其盐的试剂盒; 确定特定疾病发病或发病风险的方法，对药物易感性的测定方法和用于所述方法的测定试剂盒等。
-
4.发明申请公开(公告)号：US20090233274A1
公开(公告)日：2009-09-17
申请号：US11577575
申请日：2005-10-09
申请人： Tadakazu Yamauchi , Hideaki Sueoka , Koichi Tsuchiya , Katsuhisa Murayama , Ken Horiuchi , Kazuo Komiya , Morikazu Kito , Takeshi Kito , Takeshi Tsutsumi , Yuko Isono , Yorimasa Suwa
发明人： Tadakazu Yamauchi , Hideaki Sueoka , Koichi Tsuchiya , Katsuhisa Murayama , Ken Horiuchi , Kazuo Komiya , Morikazu Kito , Takeshi Kito , Takeshi Tsutsumi , Yuko Isono , Yorimasa Suwa
IPC分类号： C12Q1/68 , C12Q1/02 , C12N15/63 , G01N33/566 , G01N33/68 , C07K2/00 , C07K16/18 , C07K1/107 , C07H21/00 , C07J71/00 , C07D498/14 , C07D207/34
CPC分类号： C07C211/27 , A61K31/40 , C07H21/00 , C07J71/00 , C07K14/47 , G01N33/53 , G01N33/6896 , G01N33/9406 , G01N2800/2821
摘要： The present invention provides novel target proteins and target genes for drug discovery, and the means that enable the development of novel drugs using the same. More particularly, the present invention provides NCS proteins and genes thereof; screening methods for drug (for example, anti-central nervous disease drug); agents for regulating disease (for example, central nervous disease); production methods of a drug derivative; a complex comprising a drug and NCS protein, and a method of producing the complex; a kits comprising a drug or a salt thereof; determination methods for the onset or risk of onset of a specified disease, determination methods for susceptibility to a drug, and determination kits used for the determination methods; and the like.
摘要翻译： 本发明提供用于药物发现的新型靶蛋白和靶基因，以及能够开发使用其的新药物的方法。 更具体地说，本发明提供了NCS蛋白质及其基因; 药物筛选方法（如抗中枢神经病药物）; 用于调节疾病（例如中枢神经疾病）的药剂; 药物衍生物的生产方法; 包含药物和NCS蛋白质的复合物及其制备方法; 包含药物或其盐的试剂盒; 确定特定疾病发作或发病风险的方法，对药物易感性的测定方法和用于测定方法的测定试剂盒; 等等。
-
5.发明授权公开(公告)号：US08178077B2
公开(公告)日：2012-05-15
申请号：US11577575
申请日：2005-10-19
申请人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Ken Horiuchi , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Yorimasa Suwa
发明人： Tadakazu Yamauchi , Hideaki Sueoka , Kouichi Tsuchiya , Katsuhisa Murayama , Ken Horiuchi , Kazuo Komiya , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Yorimasa Suwa
IPC分类号： A61K49/00 , A01N43/64 , C07D207/00
CPC分类号： C07C211/27 , A61K31/40 , C07H21/00 , C07J71/00 , C07K14/47 , G01N33/53 , G01N33/6896 , G01N33/9406 , G01N2800/2821
摘要： The present invention provides novel target proteins and target genes for drug discovery, and the means that enable the development of novel drugs using the same. More particularly, the present invention provides NCS proteins and genes thereof; screening methods for drug (for example, anti-central nervous disease drug); agents for regulating disease (for example, central nervous disease); production methods of a drug derivative; a complex comprising a drug and NCS protein, and a method of producing the complex; a kits comprising a drug or a salt thereof; determination methods for the onset or risk of onset of a specified disease, determination methods for susceptibility to a drug, and determination kits used for the determination methods; and the like.
摘要翻译： 本发明提供用于药物发现的新型靶蛋白和靶基因，以及能够开发使用其的新药物的方法。 更具体地说，本发明提供了NCS蛋白质及其基因; 药物筛选方法（如抗中枢神经病药物）; 用于调节疾病（例如中枢神经疾病）的药剂; 药物衍生物的生产方法; 包含药物和NCS蛋白质的复合物及其制备方法; 包含药物或其盐的试剂盒; 确定特定疾病发作或发病风险的方法，对药物易感性的测定方法和用于测定方法的测定试剂盒; 等等。
-
6.发明申请公开(公告)号：US20090143285A1
公开(公告)日：2009-06-04
申请号：US11909634
申请日：2006-03-24
申请人： Hideaki Sueoka , Tadakazu Yamauchi , Kouichi Tsuchiya , Katsuhisa Murayama , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Kazuo Komiya , Noriyuki Inomata , Yorimasa Suwa , Ken Horiuchi
发明人： Hideaki Sueoka , Tadakazu Yamauchi , Kouichi Tsuchiya , Katsuhisa Murayama , Morikazu Kito , Takeshi Tsutsumi , Yuko Isono , Kazuo Komiya , Noriyuki Inomata , Yorimasa Suwa , Ken Horiuchi
IPC分类号： A61K38/16 , C12Q1/68 , G01N33/566
CPC分类号： G01N33/5023 , G01N33/68 , G01N2500/00
摘要： The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. More specifically, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
摘要翻译： 本发明提供了用于生物活性物质如药物的靶蛋白和靶基因，并且使得能够开发使用其的新型生物活性物质的手段。 更具体地，本发明提供用于生物活性物质的靶蛋白和靶基因; 能够调节生物活性的物质的筛选方法; 生物活性调节剂 生物活性物质衍生物生产方法; 包含生物活性物质和靶蛋白质的复合物，以及生产该复合物的方法; 和包含生物活性物质或其盐的试剂盒; 特定疾病或病症的发病或发病风险的确定方法，对生物活性物质易感性的测定方法和用于测定方法的测定试剂盒等。
-
7.发明申请公开(公告)号：US20110269141A1
公开(公告)日：2011-11-03
申请号：US12528190
申请日：2008-02-20
申请人： Katsuhisa Murayama , Tadakazu Yamauchi , Kouichi Tsuchiya , Kazuo Komiya , Morikazu Kito , Yuko Isono , Noriyuki Inomata , Yorimasa Suwa , Ai Wakamatsu , Junichi Yamamoto , Takao Isogai
发明人： Katsuhisa Murayama , Tadakazu Yamauchi , Kouichi Tsuchiya , Kazuo Komiya , Morikazu Kito , Yuko Isono , Noriyuki Inomata , Yorimasa Suwa , Ai Wakamatsu , Junichi Yamamoto , Takao Isogai
IPC分类号： C12Q1/68 , C07H21/04 , G01N33/50 , C07K16/00 , C07K14/00 , G01N33/68 , C07H21/02 , C12N15/63
CPC分类号： A61K31/7088 , A61K38/00 , A61K45/06 , A61K48/00 , C07K14/47 , C12Q1/6897 , G01N33/68 , G01N33/94 , G01N2500/04 , Y10T436/143333
摘要： The problems of the present invention are to provide target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. The present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
摘要翻译： 本发明的问题是提供用于生物活性物质如药物的靶蛋白和靶基因，以及能够开发使用其的新型生物活性物质的手段。 本发明提供用于生物活性物质的靶蛋白和靶基因; 能够调节生物活性的物质的筛选方法; 生物活性调节剂 生物活性物质衍生物生产方法; 包含生物活性物质和靶蛋白质的复合物，以及生产该复合物的方法; 和包含生物活性物质或其盐的试剂盒; 特定疾病或病症的发病或发病风险的确定方法，对生物活性物质易感性的测定方法和用于测定方法的测定试剂盒等。
-
8.发明申请公开(公告)号：US20080102457A1
公开(公告)日：2008-05-01
申请号：US11718946
申请日：2005-11-09
CPC分类号： G01N33/5023 , G01N33/5008 , G01N33/502
摘要： The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. To be specific, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
摘要翻译： 本发明提供了用于生物活性物质如药物的靶蛋白和靶基因，并且使得能够开发使用其的新型生物活性物质的手段。 具体而言，本发明提供了用于生物活性物质的靶蛋白和靶基因; 能够调节生物活性的物质的筛选方法; 生物活性调节剂 生物活性物质衍生物生产方法; 包含生物活性物质和靶蛋白质的复合物，以及生产该复合物的方法; 和包含生物活性物质或其盐的试剂盒; 特定疾病或病症的发病或发病风险的确定方法，对生物活性物质易感性的测定方法和用于测定方法的测定试剂盒等。
-
公开(公告)号：US08058009B2
公开(公告)日：2011-11-15
申请号：US11718946
申请日：2005-11-09
IPC分类号： G01N33/53
CPC分类号： G01N33/5023 , G01N33/5008 , G01N33/502
摘要： The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. To be specific, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
摘要翻译： 本发明提供了用于生物活性物质如药物的靶蛋白和靶基因，并且使得能够开发使用其的新型生物活性物质的手段。 具体而言，本发明提供了用于生物活性物质的靶蛋白和靶基因; 能够调节生物活性的物质的筛选方法; 生物活性调节剂 生物活性物质衍生物生产方法; 包含生物活性物质和靶蛋白质的复合物，以及生产该复合物的方法; 和包含生物活性物质或其盐的试剂盒; 特定疾病或病症的发病或发病风险的确定方法，对生物活性物质易感性的测定方法和用于测定方法的测定试剂盒等。
-
10.发明授权公开(公告)号：US07084113B2
公开(公告)日：2006-08-01
申请号：US10749387
申请日：2004-01-02
申请人： Naoyuki Fukuchi , Morikazu Kito , Takashi Kayahara , Fumie Futaki , Kohki Ishikawa , Eiichiro Suzuki , Keiko Gondoh , Nobuhisa Shimba , Naoyuki Yamada
发明人： Naoyuki Fukuchi , Morikazu Kito , Takashi Kayahara , Fumie Futaki , Kohki Ishikawa , Eiichiro Suzuki , Keiko Gondoh , Nobuhisa Shimba , Naoyuki Yamada
CPC分类号： C07K14/46 , C07K14/745
摘要： A method for producing a protein having an antithrombotic activity, which comprises replacing, in a protein that has an amino acid sequence having a homology of not less than 30% to the amino acid sequence of SEQ ID NO: 1 and forms a higher order structure composed of a first β strand (β1), a first a helix (α1), a second α helix (α2), a second β strand (β2), a loop, a third β strand (β3), a fourth β strand (β4) and a fifth β strand (β5) in this order from the amino terminus, at least one amino acid residue in a region from α2 to β2 and/or a region from β3 to β4 so that electric charge of the amino acid residue is changed towards positive direction.
摘要翻译： 一种具有抗血栓形成活性的蛋白质的制造方法，其特征在于，具有与SEQ ID NO：1的氨基酸序列具有不小于30％的同源性的氨基酸序列的蛋白质，并形成高级结构 由第一个β链（beta1），第一个螺旋（alpha1），第二个α螺旋（alpha2），第二个β链（β2），一个环，第三个β链（β3），第四个β链 β4）和第五个β链（β5），从氨基末端起始，α2至β2区域和/或β3至β4区域中的至少一个氨基酸残基，使得氨基酸残基的电荷为 转向正向。
-
-
-
-
-
-
-
-
-
搜索结果
23 条记录 (耗时 0.044 秒)
